204 related articles for article (PubMed ID: 32169361)
1. Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database-based Study.
Pecoraro A; Palumbo C; Knipper S; Mistretta FA; Rosiello G; Tian Z; St-Hilaire PA; Shariat SF; Saad F; Lavallée L; Briganti A; Kapoor A; Fiori C; Porpiglia F; Karakiewicz PI
Eur Urol Focus; 2021 Jul; 7(4):818-826. PubMed ID: 32169361
[TBL] [Abstract][Full Text] [Related]
2. Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma.
Pecoraro A; Palumbo C; Knipper S; Rosiello G; Luzzago S; Tian Z; Shariat SF; Saad F; Lavallée L; Briganti A; Kapoor A; Fiori C; Porpiglia F; Karakiewicz PI
Clin Genitourin Cancer; 2020 Oct; 18(5):e610-e618. PubMed ID: 32173357
[TBL] [Abstract][Full Text] [Related]
3. Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma.
Rosiello G; Palumbo C; Knipper S; Pecoraro A; Luzzago S; Tian Z; Larcher A; Capitanio U; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Urol Oncol; 2020 May; 38(5):537-544. PubMed ID: 32122729
[TBL] [Abstract][Full Text] [Related]
4. Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study.
Pecoraro A; Deuker M; Rosiello G; Stolzenbach F; Luzzago S; Tian Z; Shariat SF; Saad F; Briganti A; Kapoor A; Fiori C; Porpiglia F; Karakiewicz PI
Urol Oncol; 2021 Apr; 39(4):239.e1-239.e7. PubMed ID: 33602621
[TBL] [Abstract][Full Text] [Related]
5. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
6. A Population Study to Identify Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Sarcomatoid Renal Cell Carcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database.
Ji B; Li D; Fu S; Zhang Z; Yang T; Wu Y; Zuo Y; Xu Z; Yu N
Med Sci Monit; 2020 Jun; 26():e921297. PubMed ID: 32516796
[TBL] [Abstract][Full Text] [Related]
7. Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines.
Pecoraro A; Rosiello G; Luzzago S; Deuker M; Stolzenbach F; Tian Z; Shariat SF; Saad F; Briganti A; Kapoor A; Fiori C; Porpiglia F; Karakiewicz PI
J Natl Compr Canc Netw; 2020 Oct; 18(10):1340-1347. PubMed ID: 33022641
[TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
9. Patient and tumor characteristics of histological subtypes of renal cell carcinoma and its risk of upstaging to ≥pT3.
Wenzel M; Hoeh B; Cano Garcia C; Bernatz S; Köllermann J; Kluth LA; Chun FKH; Becker A; Mandel P
Urol Oncol; 2023 Dec; 41(12):487.e7-487.e13. PubMed ID: 37758628
[TBL] [Abstract][Full Text] [Related]
10. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
Beck SD; Patel MI; Snyder ME; Kattan MW; Motzer RJ; Reuter VE; Russo P
Ann Surg Oncol; 2004 Jan; 11(1):71-7. PubMed ID: 14699037
[TBL] [Abstract][Full Text] [Related]
11. Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non-clear Cell Renal Cell Carcinoma Patients.
Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Mistretta FA; Tian Z; Musi G; Montanari E; Soulières D; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Eur Urol Focus; 2021 May; 7(3):598-607. PubMed ID: 32444303
[TBL] [Abstract][Full Text] [Related]
12. Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation.
Nocera L; Collà Ruvolo C; Stolzenbach LF; Wenzel M; Tian Z; Larcher A; Capitanio U; Mirone V; Tilki D; Chun FKH; Kapoor A; Shariat SF; Saad F; Montorsi F; Briganti A; Karakiewicz PI
Eur Urol Focus; 2022 Jan; 8(1):182-190. PubMed ID: 33653677
[TBL] [Abstract][Full Text] [Related]
13. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
Siddiqui SA; Frank I; Cheville JC; Lohse CM; Leibovich BC; Blute ML
BJU Int; 2009 Sep; 104(6):778-85. PubMed ID: 19338559
[TBL] [Abstract][Full Text] [Related]
14. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
[TBL] [Abstract][Full Text] [Related]
15. The Metastasis Pattern of Renal Cell Carcinoma Is Influenced by Histologic Subtype, Grade, and Sarcomatoid Differentiation.
Park HK
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893563
[No Abstract] [Full Text] [Related]
16. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
[TBL] [Abstract][Full Text] [Related]
17. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract][Full Text] [Related]
19. The Metastatic Risk of Renal Cell Carcinoma by Primary Tumor Size and Subtype.
Monda SM; Lui HT; Pratsinis MA; Chandrasekar T; Evans CP; Dall'Era MA
Eur Urol Open Sci; 2023 Jun; 52():137-144. PubMed ID: 37284045
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
